Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AYLA | PSTV | CANF | ||
| Company | Ayala Pharmaceuticals Inc | Plus Therapeutics Inc | Can-Fite Biopharma Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 0.4876 | 1.2600 | 2.06 | ||
| High | 0.5698 | 1.3150 | 2.14 | ||
| Low | 0.4399 | 1.2500 | 1.98 | ||
| Last | 0.5036 | 1.2600 | 1.99 | ||
| Change | +0.0278 | -0.0500 | -0.08 | ||
| % Change | +5.84% | -3.82% | -3.86% | ||
| Volume | 137,700 | 83,000 | 49,100 | ||
| 20-Day Average Volume | 60,750 | 103,335 | 71,835 | ||
| Previous Close | 0.4758 | 1.3100 | 2.07 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4529 | 1.3387 | 2.33 | ||
| 20-Day Raw Stochastic | 62.79% | 28.13% | 0.88% | ||
| 20-Day Relative Strength | 47.42% | 44.09% | 39.16% | ||
| Weighted Alpha | -90.06 | -32.03 | -45.31 | ||
| Today's Opinion | 80% Sell | 100% Sell | 72% Sell | ||
| Previous Opinion | 80% Sell | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.27% since 01/10/23 | -7.35% since 11/07/24 | -2.93% since 11/07/24 | ||
| Low | 0.4399 on 01/18/23 | 1.1700 on 11/11/24 | 1.98 on 11/14/24 | ||
| High | 0.5830 on 01/11/23 | 1.4200 on 11/13/24 | 2.22 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | +0.68% since 12/16/22 | -4.55% since 10/14/24 | -21.03% since 10/14/24 | ||
| Low | 0.3568 on 01/03/23 | 1.1700 on 11/11/24 | 1.98 on 11/14/24 | ||
| High | 0.5906 on 01/10/23 | 1.4900 on 11/06/24 | 3.12 on 10/21/24 | ||
| 3-Month | |||||
| %Chg | -44.75% since 10/18/22 | -11.27% since 08/14/24 | -22.27% since 08/14/24 | ||
| Low | 0.3568 on 01/03/23 | 1.1450 on 09/09/24 | 1.87 on 09/20/24 | ||
| High | 0.9611 on 10/19/22 | 1.9400 on 09/27/24 | 3.12 on 10/21/24 | ||
| 6-Month | |||||
| %Chg | -50.63% since 07/18/22 | -41.94% since 05/14/24 | -6.57% since 05/14/24 | ||
| Low | 0.3568 on 01/03/23 | 1.1450 on 09/09/24 | 1.87 on 09/20/24 | ||
| High | 2.4200 on 07/26/22 | 2.6702 on 06/05/24 | 4.69 on 07/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,464 | 7,724 | 7,328 | ||
| Shares Outstanding, K | 14,821 | 5,896 | 3,540 | ||
| Annual Sales | 3,510,000 | 4,910,000 | 740,000 | ||
| Annual Net Income | -40,250,000 | -13,320,000 | -7,630,000 | ||
| Last Quarter Sales | 90,000 | 1,280,000 | 160,000 | ||
| Last Quarter Net Income | -10,190,000 | -2,940,000 | -1,650,000 | ||
| 60-Month Beta | 1.98 | 0.69 | 1.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/04/22 | -0.71 on 08/14/24 | -0.31 on 03/28/24 | ||
| Latest Earnings Date | 11/21/22 | 11/14/24 | 12/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||